Table III. Impact of HER2-immunohistochemical expression on response to neoadjuvant chemotherapy (NAC) in hormonal receptor-positive and HER2-negative early breast cancer patients.

HER2: Human epidermal growth factor receptor-2; ISH: in situ hybridization; pCR: pathological complete response.